• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母体血清游离β-hCG 稳定性:苏格兰第一孕期唐氏综合征筛查中全血样本转运后的情况。

Stability of maternal serum free β-hCG following whole blood sample transit: First trimester Down's syndrome screening in Scotland.

机构信息

Department of Clinical Biochemistry, 59892Western General Hospital, Edinburgh, UK.

出版信息

Ann Clin Biochem. 2022 Jan;59(1):87-91. doi: 10.1177/00045632211045250. Epub 2021 Oct 18.

DOI:10.1177/00045632211045250
PMID:34657475
Abstract

BACKGROUND

Maternal serum free beta human chorionic gonadotrophin (free β-hCG) is used as a biomarker in first trimester screening for fetal Down's syndrome. Production of free β-hCG can occur in vitro in a time- and temperature-dependent manner; thus, the current Scottish screening protocol states samples must be received by the laboratory within 72 h. To assess the validity of the protocol, an audit was conducted to determine the impact of transit time on maternal serum free β-hCG multiple of median (MoM) values in the Scottish screened population.

METHODS

Corrected MoM values from antenatal screening carried out over one year (April 2017 to March 2018) were stratified according to sample transit time and compared. To investigate possible environmental temperature effects, the data were split according to season and maternal serum free β-hCG concentrations from summer and winter compared.

RESULTS

Of the 28,368 samples included in the study, 24,368 were received on the day of phlebotomy or after one day in transit. Only 1.5% of samples were received after 3 days in transit. The difference in maternal serum free β-hCG MoM values due to transit time was not significant. No statistical difference was found between maternal serum free β-hCG concentrations from samples collected in summer and winter months.

CONCLUSION

The current sample receipt protocol in use by the Scottish Down's syndrome screening programme is fit for purpose.

摘要

背景

母体血清游离人绒毛膜促性腺激素(游离β-hCG)被用作唐氏综合征胎儿早孕期筛查的生物标志物。游离β-hCG 的产生可以在体外以时间和温度依赖的方式发生;因此,目前苏格兰的筛查方案规定,样本必须在 72 小时内送达实验室。为了评估该方案的有效性,进行了一项审计,以确定运输时间对苏格兰筛查人群母体血清游离β-hCG 中位数倍数(MoM)值的影响。

方法

根据样本运输时间对在一年(2017 年 4 月至 2018 年 3 月)进行的产前筛查中的校正 MoM 值进行分层,并进行比较。为了研究可能的环境温度影响,根据季节对数据进行了拆分,并比较了夏季和冬季的母体血清游离β-hCG 浓度。

结果

在研究中纳入的 28368 个样本中,24368 个样本在采血当天或运输后一天送达。只有 1.5%的样本在运输后 3 天送达。由于运输时间的差异,母体血清游离β-hCG MoM 值的差异并不显著。在夏季和冬季采集的样本中,母体血清游离β-hCG 浓度之间未发现统计学差异。

结论

目前苏格兰唐氏综合征筛查计划中使用的样本接收方案是可行的。

相似文献

1
Stability of maternal serum free β-hCG following whole blood sample transit: First trimester Down's syndrome screening in Scotland.母体血清游离β-hCG 稳定性:苏格兰第一孕期唐氏综合征筛查中全血样本转运后的情况。
Ann Clin Biochem. 2022 Jan;59(1):87-91. doi: 10.1177/00045632211045250. Epub 2021 Oct 18.
2
Correlations between maternal hepatitis B virus carrier status and Down's syndrome prenatal screening indicators and their effects on the screening results.母体乙型肝炎病毒携带状态与唐氏综合征产前筛查指标的相关性及其对筛查结果的影响。
J Obstet Gynaecol. 2022 Oct;42(7):2793-2798. doi: 10.1080/01443615.2022.2109409. Epub 2022 Aug 27.
3
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.孕早期唐氏综合征的母体血清筛查:DPC Immulite 2000游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A检测方法的评估
Ann Clin Biochem. 2005 Jan;42(Pt 1):30-40. doi: 10.1258/0004563053026880.
4
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.妊娠8至14周时唐氏综合征的血清筛查。国际产前筛查研究小组。
Br J Obstet Gynaecol. 1996 May;103(5):407-12. doi: 10.1111/j.1471-0528.1996.tb09765.x.
5
Screening of maternal serum for fetal Down's syndrome in the first trimester.孕早期母体血清筛查胎儿唐氏综合征
N Engl J Med. 1998 Apr 2;338(14):955-61. doi: 10.1056/NEJM199804023381404.
6
Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.孕早期唐氏综合征筛查联合测量胎儿颈部透明带厚度、母体血清游离β-人绒毛膜促性腺激素及妊娠相关血浆蛋白A。
J Formos Med Assoc. 2001 May;100(5):319-25.
7
Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.孕早期母体血清甲胎蛋白和游离β-人绒毛膜促性腺激素分析:对唐氏综合征筛查的意义
Prenat Diagn. 1995 Jun;15(6):555-65. doi: 10.1002/pd.1970150609.
8
Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.孕早期联合超声与生化筛查唐氏综合征:一项苏格兰多中心研究。
BJOG. 2002 Jun;109(6):667-76. doi: 10.1111/j.1471-0528.2002.01394.x.
9
SURUSS in perspective.透视下的SURUSS
Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006.
10
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.唐氏综合征筛查:孕早期与孕中期标志物水平及检出率的变化
Br J Obstet Gynaecol. 1997 Jul;104(7):811-7. doi: 10.1111/j.1471-0528.1997.tb12025.x.

引用本文的文献

1
Predictive value of prenatal screening markers combined with serum placental growth factor in early pregnancy for preeclampsia.孕早期产前筛查标志物联合血清胎盘生长因子对先兆子痫的预测价值
Pak J Med Sci. 2025 Feb;41(2):598-602. doi: 10.12669/pjms.41.2.9794.
2
Human Chorionic Gonadotropin and Early Embryogenesis: Review.人绒毛膜促性腺激素与早期胚胎发生:综述。
Int J Mol Sci. 2022 Jan 26;23(3):1380. doi: 10.3390/ijms23031380.